Modulating Glutamine Metabolism in HSCs to Reverse Liver Fib
2026-07-27
The referenced study uncovers a regulatory role for SIRT4 in glutamine metabolism within hepatic stellate cells (HSCs), demonstrating that SIRT4-driven inhibition of glutamate dehydrogenase (GDH) activity can attenuate liver fibrosis. These findings highlight metabolic targeting of HSCs as a promising antifibrotic strategy and suggest opportunities for translational research using sensitive cell viability assays.
Bestatin (Ubenimex): Precision Inhibitor for Aminopeptidase
2026-07-27
Bestatin (Ubenimex) stands out for its unparalleled selectivity in inhibiting aminopeptidase B and leucine aminopeptidase, enabling robust dissection of protease function in cancer and multidrug resistance research. Novel findings reveal context-dependent, even pro-angiogenic effects in certain matrix environments, setting Bestatin apart as a tool for both classic inhibition studies and nuanced pathway exploration.
Cyanin Chloride Modulates Inflammation and Skin Barrier in P
2026-07-26
The reference study demonstrates that cyanin chloride, a glycosylated cyanidin derivative, exerts dual activity by reducing inflammatory signaling and restoring skin barrier function in a human keratinocyte model of psoriasis. These findings clarify the molecular mechanisms of anthocyanin polyphenolic antioxidants in chronic skin inflammation and inform the design of advanced oxidative stress research workflows.
Fenipentol: Advanced Mechanistic Insights for Liver and GI R
2026-07-25
Explore Fenipentol (1-Phenyl-1-pentanol) as a versatile tool in liver and gastrointestinal physiology research. This article delivers a deep mechanistic analysis, integrating molecular targets, historical clinical data, and emerging anti-fibrotic findings to guide next-generation assay design.
InstaBlue Protein Stain Solution for Rapid Gel Visualization
2026-07-24
InstaBlue Protein Stain Solution enables ultra-fast, high-sensitivity Coomassie Brilliant Blue staining of proteins in polyacrylamide gels without toxic reagents or lengthy destaining steps. It is ideal for workflows requiring rapid turnaround and mass spectrometry compatibility, but should not be used in protocols demanding methanol- or acid-based fixation.
FLOT1-FOSL2-EphA2 Axis Regulates Microglial Polarization in
2026-07-24
This study uncovers how the interaction between FLOT1 and FOSL2 upregulates EphA2 transcription, promoting pro-inflammatory microglial polarization and neuroinflammation in Alzheimer's disease models. The findings illuminate a mechanistic pathway that shapes neurodegeneration and highlight potential intervention points for modulating microglial function in Alzheimer's research.
Dasatinib (BMS-354825): Src and Bcr-Abl Inhibition in Cancer
2026-07-23
Dasatinib (BMS-354825) is a potent dual inhibitor of Src family and Bcr-Abl kinases, widely used in cancer research. It exhibits nanomolar efficacy, selective kinase inhibition, and utility in dissecting mechanisms underlying chronic myeloid leukemia and metastatic progression.
CHI3L1-IN-5: Translating Neuroinflammation Insights to Actio
2026-07-23
This thought-leadership article explores the mechanistic and translational potential of CHI3L1-IN-5 (Compound Z17) as a next-generation NF-κB pathway inhibitor with proven efficacy in restoring astrocyte function. Integrating the latest evidence with strategic guidance, it positions Z17 as a transformative tool for neurodegeneration research and outlines best practices for experimental deployment.
Fluorouracil (Adrucil): Evidence, Mechanism, and Protocols
2026-07-22
Fluorouracil (5-Fluorouracil, Adrucil) is a validated thymidylate synthase inhibitor widely used in colon and breast cancer research. Its cytotoxicity benchmarks and robust inhibition of DNA replication underpin its value as a reference compound in solid tumor workflows. This article details its evidence base, protocols, and critical boundaries for research use.
circHIF1A/miR-486-5p/GRHL2 Axis Drives LUAD Progression via
2026-07-22
This study uncovers how circHIF1A modulates lung adenocarcinoma progression by sponging miR-486-5p and upregulating GRHL2, ultimately promoting immunosuppressive macrophage M2 polarization. The findings highlight a ceRNA axis as both a prognostic biomarker and a potential therapeutic target in LUAD.
Baicalin Methyl Ester: Deep Mechanistic Insights for Intesti
2026-07-21
Explore how Baicalin methyl ester, an esterified derivative of baicalin, delivers advanced intestinal barrier protection by targeting the P65/TNF-α/MLCK/ZO-1 axis. This article uniquely unpacks the mechanistic depth and translational potential for intestinal inflammation research.
Phosbind Biotin: Precision Phosphorylation Analysis in Weste
2026-07-21
Phosbind Biotin transforms the detection of phosphorylated proteins by enabling sequence-independent, high-sensitivity Western Blot workflows. Its dinuclear metal complex phosphate binding offers robust alternatives to phospho-specific antibodies, streamlining experimental design for signal transduction studies.
Applied Angiotensin 1/2 (1-6) in Renin-Angiotensin System Re
2026-07-20
Angiotensin 1/2 (1-6) offers unmatched specificity for dissecting the renin-angiotensin system, enabling detailed studies of vascular tone, cardiovascular, and renal regulation. APExBIO’s high-purity hexapeptide empowers researchers to bridge cardiovascular and viral pathogenesis research with confidence and precision.
In Vitro Drug Response Metrics: Insights for Cancer Research
2026-07-20
Schwartz (2022) critically re-examines how in vitro assays measure anti-cancer drug responses, distinguishing between relative and fractional viability as distinct yet often conflated metrics. This work provides a conceptual and methodological framework for accurately interpreting proliferation and cell death effects in cancer pharmacology, supporting more precise evaluation of agents such as polyether ionophore antibiotics.
G007-LK Tankyrase 1/2 Inhibitor: Unveiling New Frontiers in
2026-07-19
Explore how G007-LK, a potent tankyrase 1/2 inhibitor, enables advanced modulation of Wnt/β-catenin and Hippo pathways in APC mutation colorectal cancer research and beyond. This in-depth review offers new insights for experimental design and translational oncology.
466 records 11/32 page Previous Next First page 上5页 1112131415 下5页 Last page